Nocturia

  • Jeffrey P. Weiss
  • Jerry G. Blaivas

Abstract

To review the current state of knowledge and present algorithms for diagnosis, classification, and treatment of nocturia.

Keywords

Fatigue Angiotensin Caffeine Prostaglandin Neurol 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Abyholm G, Monn E: Intranasal DDAVP test in the study of renal concentrating ability in children with recurrent urinary tract infections. Eur J Pediatr, 130:149, 1979.PubMedCrossRefGoogle Scholar
  2. 2.
    Abrams P, Blaivas JG, Stanton S, Andersen JT: The standardization of terminology of lower urinary tract function. International Continence Society Committee on standardization of terminology. Scand J Urol Nephrol, 114(Suppl):5, 1988.Google Scholar
  3. 3.
    Adam P: Evaluation and management of diabetes insipidus. Am Fam Physician, 55(6):2146, 1997.PubMedGoogle Scholar
  4. 4.
    Al-Waili NS: Diclofenac sodium in the treatment of primary nocturnal enuresis: Double-blind crossover study. Clin Exp Pharm & Physiology, 13:139, 1986.CrossRefGoogle Scholar
  5. 5.
    Al-Waili NS: Indometacin suppositories: an alternative treatment for nocturnal frequency of micturition. IRCS Med Sci, 14:322, 1986.Google Scholar
  6. 6.
    Andersson KE, Arner B: Effects of DDAVP, a synthetic analogue of vasopressin in patients with cranial diabetes insipidus. Acta Med Scand, 192:21, 1972.PubMedCrossRefGoogle Scholar
  7. 7.
    Aronson AS, Andersson KE, Bergstrand CG, Mulder JL: Treatment of diabetes insipidus in children with DDAVP, a synthetic analogue of vasopressin. Acta Paediatr Scand, 62:133, 1973.PubMedCrossRefGoogle Scholar
  8. 8.
    Aronson AS, Svenningsen NW: DDAVP test for estimation of renal concentrating capacity in infants and children. Arch Dis Child, 49:654, 1974.PubMedCrossRefGoogle Scholar
  9. 9.
    Asplund R, Åberg H: Diurnal variation in the levels of antidiuretic hormone in elderly subjects with nocturia. Med Sci Res, 19:765, 1991.Google Scholar
  10. 10.
    Asplund R, Aberg H: Desmopressin in elderly subjects with increased nocturnal diuresis. A two-month treatment study [Ph.D. Thesis]. Dr. Ragnar Asplund, Karolinska Institute, Stockholm, Sweden, 1992.Google Scholar
  11. 11.
    Asplund R, Åberg HE: Micturition habits of older people. Voiding frequency and urine volumes. Scand J Urol Nephrol, 26:345, 1992.PubMedCrossRefGoogle Scholar
  12. 12.
    Asplund R, Åberg H: Desmopressin in elderly subjects with increased nocturnal diuresis. Scand J Urol Nephrol, 27B:77, 1993.CrossRefGoogle Scholar
  13. 13.
    Asplund R, Åberg H.: Desmopressin in elderly women with increased nocturnal diuresis. A short-term study. Brit J Urol, 72A:42, 1993.CrossRefGoogle Scholar
  14. 14.
    Asplund R: The Nocturnal Polyuria Syndrome (NPS). Gen Pharmac, 26(6): 1203, 1995.CrossRefGoogle Scholar
  15. 15.
    Asplund R, Åberg H: Nocturnal micturition, sleep and well-being in women of ages 40–64 years. Maturitas, 24:73, 1996.PubMedCrossRefGoogle Scholar
  16. 16.
    Asplund R, Sundberg B, Bengtsson P: Desmopressin for the treatment of nocturnal polyuria in elderly subjects: a dose titration study. Br J Urol, 82:5, 1998.CrossRefGoogle Scholar
  17. 17.
    Asplund R, Sundberg B, Bengtsson P: Oral desmopressin for nocturnal polyuria in 60–74 year old subjects: a double-blind, randomised exploratory study. Br J Urol, 83:591, 1999.Google Scholar
  18. 18.
    Barker JC, Mitteness LS: Nocturia in the elderly. Gerontologist, 28:99, 1988.PubMedCrossRefGoogle Scholar
  19. 19.
    Barry MJ, Fowler FJ, O’Leary MP, Bruskewitz RC, Holtgrewe HL, the Measurement Committee of the American Urological Association: The American Urological Association Symptom Index for benign prostatic hyperplasia. J Urol, 148:1549, 1992.PubMedGoogle Scholar
  20. 20.
    Baylis PH: Osmoregulation and control of vasopressin secretion in healthy humans. Am J Physiol, 235(5 Pt 2):R671, 1987.Google Scholar
  21. 21.
    Belmaker RH: The use of desmopressin in adult enuresis. Military Med, 151(12):660, 1986.Google Scholar
  22. 22.
    Blaivas JG, Stember DS, Weiss JP: Etiology of voiding symptoms in men: Correlation of individual AUA symptom scores with urodynamic and diary parameters. Neurourol Urodyn, 17:398, 1998.Google Scholar
  23. 23.
    Bliwise DL, King AC, Harris RB: Habitual sleep durations and health in a 50–65 year old population. J Clin Epidemiol, 47(1):34, 1994.CrossRefGoogle Scholar
  24. 24.
    Britton JP, Dowell AC, Whelan P: Prevalence of urinary symptoms in men aged over 60. Brit J Urol, 66(2):175, 1990.PubMedCrossRefGoogle Scholar
  25. 25.
    Broman JE, Lundh LG, Hetta J: Insufficient sleep in the general population. Neurophysiol Clin, 26(1):30, 1996.PubMedCrossRefGoogle Scholar
  26. 26.
    Bruskewitz RC, Larsen EH, Madsen PO, Dorflinger T: 3-year follow-up of urinary symptoms after transuretheral resection of the prostate. J Urol, 136:613, 1986.PubMedGoogle Scholar
  27. 27.
    Chancellor MB, Rivas DA, Staas WE, Jr: DDAVP in the urological management of difficult neurogenic bladder in spinal cord injury: a preliminary report. J Am Paraplegia Soc, 17(4):165, 1994.PubMedGoogle Scholar
  28. 28.
    Chanson P, Jedynak CP, Czernichow P: Management of early postoperative diabetes insipidus with parenteral desmopressin. Acta Endincrol (Copenh), 117:513, 1988.Google Scholar
  29. 29.
    Cunnah D, Ross G, Besser GM: Management of cranial diabetes insipidus with oral desmopressin (DDAVP). Clin Endincrol, 24(3):253, 1986.CrossRefGoogle Scholar
  30. 30.
    Delaere KPJ, Strijbos WEM: Antidiuretic approach with DDAVP for nocturnal enuresis. Acta Urol Bel, 54:464, 1986.Google Scholar
  31. 31.
    Desgranchamps F, Cortesse A, Rousseau T, Teillac P, Duc AL: Normal voiding behaviour in women. Study of the I-PSS in an unselected population of women in general practice. Eur Urol, 30(1): 18, 1996.Google Scholar
  32. 32.
    Dimson SB: Desmopressin as a treatment for enuresis. Lancet, 1:1260, 1977.PubMedCrossRefGoogle Scholar
  33. 33.
    Donahue JL, Lowenthal DT: Nocturnal polyuria in the elderly person. Am J Med Sci, 314(4):232, 1997.PubMedCrossRefGoogle Scholar
  34. 34.
    DuBeau CE, Yalla SV, Resnick NM: Implications of the most bothersome prostatism symptom for clinical care and outcomes research. J Am Geriatrics Soc, 43(9):985, 1995.Google Scholar
  35. 35.
    Everaert K, Pevernagie D, Oosterlinck W: Nocturnal enuresis provoked by an obstructive sleep apnea syndrome. J Urol, 153(4):1236, 1995.PubMedCrossRefGoogle Scholar
  36. 36.
    Fjellestad-Paulsen A, Czernichow P: Central diabetes insipidus in children. Acta Paediatr Scand, 75:605, 1986.CrossRefGoogle Scholar
  37. 37.
    Fjellestad-Paulsen A, Wille S, Harris AS: Comparison of intranasal and oral desmopessin for nocturnal enuresis. Arch Dis Child, 62:674, 1987.PubMedCrossRefGoogle Scholar
  38. 38.
    Fredriksson S: Nasal spray desmopressin treatment of bladder dysfunction in patients with multiple sclerosis. Acta Neurol Scand, 94:31, 1996.CrossRefGoogle Scholar
  39. 39.
    Fultz HL, Herzog AR: Epidemiology of urinary symptoms in the geriatric population. Urol Clin North Am, 23(1): 1, 1996.PubMedCrossRefGoogle Scholar
  40. 40.
    Gajewski JB, Awad SA: Oxybutynin versus propantheline in patients with multiple sclerosis and detrusor hyperreflexia. J Urol, 135(5):966, 1986.PubMedGoogle Scholar
  41. 41.
    Gislason T, Almqvist M: Somatic diseases and sleep complaints. An epidemiological study of 3201 Swedish men. Acta Med Scand, 221(5):475, 1987.PubMedCrossRefGoogle Scholar
  42. 42.
    Griffiths DJ, McCracken PN, Harrison GM, Gormley EA: Characteristics of urinary incontinence in elderly patients studied by 24-hour monitoring and urodynamic testing. Age Ageing, 21:195, 1992.PubMedCrossRefGoogle Scholar
  43. 43.
    Hammer M: Peroral treatment of diabetes insipidus with a polypeptide hormone analogue, desmopressin. J Pharmacol Exp Ther, 234(3):754, 1985.PubMedGoogle Scholar
  44. 44.
    Hedner J: Vascular function in OSA. Sleep, 19:S213, 1996.PubMedGoogle Scholar
  45. 45.
    Hennessy CH, Shen JKM: Sources of unreliability in the multidisciplinary team assessment of the elderly. Evaluation Review, 10:178, 1986.CrossRefGoogle Scholar
  46. 46.
    Hetta J, Rimon R, Almqvist M: Mood alterations and sleep. Ann Clin Res, 17:252, 1985.PubMedGoogle Scholar
  47. 47.
    Hilton P, Stanton SL: The use of desmopressin (DDAVP) in nocturnal urinary frequency in the female. Brit J Urol, 54:252, 1982.PubMedCrossRefGoogle Scholar
  48. 48.
    Hilton P, Hertogs K, Stanton SL: The use of desmopressin (DDAVP) in nocturia in women with multiple sclerosis. J Nephrol Neurosurg Psychiatry, 46:854, 1983.CrossRefGoogle Scholar
  49. 49.
    Homma Y, Imajo C, Takahashi S, Kawabe K, Aso Y: Urinary symptoms and urodynamics in a normal elderly population. Scan J Urol Nephrol, 157(Suppl):27, 1994.Google Scholar
  50. 50.
    Hunsballe J, Rittig S, Pederson E, Oleson O, Djurhuus J: Single dose Imipramine reduces nocturnal urine output in patients with nocturnal enuresis and nocturnal polyuria. J Urol, 158:830, 1997.PubMedCrossRefGoogle Scholar
  51. 51.
    Hyyppa MT, Kronholm E: Quality of sleep and chronic illnesses. J Clin Epidemiol, 42(7):633, 1989.PubMedCrossRefGoogle Scholar
  52. 52.
    Janknegt RA, Smans AJ: Treatment with desmopressin in severe nocturnal enuresis in childhood. Brit J Urol, 66:535, 1990.PubMedCrossRefGoogle Scholar
  53. 53.
    Jolleys JV, Donovan JL, Nanchahal K, Peters TJ, Abrams P: Urinary symptoms in the community: how bothersome are they? Brit J Urol, 74(5):551, 1994.PubMedCrossRefGoogle Scholar
  54. 54.
    Kikuchi Y: Participation of atrial natriuretic peptide (hANP) levels and arginine vasopressin (AVP) in aged persons with nocturia. Jap J Urol, 86(11):1651, 1995.PubMedGoogle Scholar
  55. 55.
    Kinn AC, Larsson PO: Desmopressin: a new principle for symptomatic treatment of urgency and incontinence in patients with multiple sclerosis. Scand J Urol Nephrol, 24(2):109, 1990.PubMedCrossRefGoogle Scholar
  56. 56.
    Klauber GT: Clinical efficacy and safety of desmopressin in the treatment of nocturnal enuresis. J Paediatrics, 114:719, 1989.CrossRefGoogle Scholar
  57. 57.
    Knudsen UB, Rittig S, Nørgaard JP, Lundemose JB, Pedersen EB, Djurhuus JC: Long-term treatment of nocturnal enuresis with desmopressin. A follow-up study. Urol Res, 19:237, 1991.PubMedCrossRefGoogle Scholar
  58. 58.
    Krieger J, Laks L, Wilcox I, Grunstein RR, Costas LJ, McDougall JG, et al: Atrial natriuretic peptide release during sleep in patients with obstructive sleep apnea before and during treatment with continuous positive airway pressure. Clin Sci, 77:407, 1989.PubMedGoogle Scholar
  59. 59.
    Krieger J, Petian C, Sforza E, Delano C, Hecht MT, Chamovard V: Nocturnal pollakiuria is a symptom of obstructive sleep apnea. Urol Int, 50:93, 1993.PubMedCrossRefGoogle Scholar
  60. 60.
    Lam KSL, Wat MS, Choi KL, Ip TP, Pang WC, Kumana CR: Pharmacokinetics, pharmacodynamics, long-term efficacy and safety of oral 1-deamino-8-D-arginine vasopressin in adult patients with central diabetes insipidus. Brit J Pharmacol, 42:379, 1996.Google Scholar
  61. 61.
    Lindberg E, Janson C, Gislason T, Bjornsson E, Hetta J, Boman G: Sleep disturbances in a young adult population: can gender differences be explained by differences in psychological status? Sleep, 20(6):381, 1997.PubMedGoogle Scholar
  62. 62.
    Lose Gunnar: Unpublished data (personal communication).Google Scholar
  63. 63.
    Mannucci PM: Desmopressin: A nontransfusional form of treatment for congenital and acquired bleeding disorders. Blood, 72:1449, 1988.PubMedGoogle Scholar
  64. 64.
    Månsson W, Sundin T, Gullberg B: Evaluation of synthetic vasopressin analogue for treatment of nocturia in benign prostatic hypertrophy. Scand J Urol Nephrol, 14:139, 1980.PubMedCrossRefGoogle Scholar
  65. 65.
    Mathias CJ, Fosbraey P, da Costa D, Thornley A, Bannister R: The effect on desmopressin on nocturnal polyuria, overnight weight loss and morning postural hypotension in patients with autonomic failure. BMJ, 293:353, 1986.PubMedCrossRefGoogle Scholar
  66. 66.
    Matthiesen TB, Rittig S, Norgaard JP, Pedersen EB, Djurhuus JC: Nocturnal polyuria and natriuresis in male patients with nocturia and lower urinary tract symptoms. J Urol, 156:1292, 1996.PubMedCrossRefGoogle Scholar
  67. 67.
    Middlekoop HA, Smilde-van den Doel DA, Neven AK, Kamphuisen HA, Springer CP: Subjective sleep characteristics of 1485 males and females aged 50–93: effects of sex and age, and factors related to self-evaluated quality of sleep. J Gerontol A Biol Sci Med Sci, 51(3):M108, 1996.CrossRefGoogle Scholar
  68. 68.
    Miller K, Goldberg S, Atkin B: Nocturnal enuresis: experience with long-term use of intranasally administered desmopressin. J Paediatr, 114:723, 1989.CrossRefGoogle Scholar
  69. 69.
    Miller M, Dalakos AM, Gellerman H, Streeter DHP: Recognition of partial defects in antidiuretic hormone secretion. Ann Intern Med, 73:721, 1970.PubMedCrossRefGoogle Scholar
  70. 70.
    Muskat Y, Bukovsky I, Schneider D, Langer R: The use of scopolamine in the treatment of detrusor instability. J Urol, 156(6): 1989, 1996.PubMedCrossRefGoogle Scholar
  71. 71.
    Naitoh P, Kelly TL, Englund C: Health effects of sleep deprivation. Occup Med, 5:209, 1990.PubMedGoogle Scholar
  72. 72.
    Nørgaard JP: Pathophysiology of nocturnal enuresis. Scand J Urol Nephrol, 140(Suppl):13, 1991.Google Scholar
  73. 73.
    Partinen M: Epidemiology of obstructive sleep apnea syndrome. Curr Opin Pulm Med, 1(6):482, 1995.PubMedCrossRefGoogle Scholar
  74. 74.
    Pedersen PA, Johansen PB: Prophylactic treatment of adult nocturia with bumetanide. Br J Urol, 62(2): 145, 1988.PubMedCrossRefGoogle Scholar
  75. 75.
    Phillips PA, Bretherton M, Johnston C, Gray L: Reduced osmotic thirst in healthy elderly men. Am. J. Physiol., 261(1 P2):R166, 1991.PubMedGoogle Scholar
  76. 76.
    Post EM, Richman RA, Blackett PR, Duncan KP, Miller K: Desmopressin response of enuretic children. Effects of age and frequency of enuresis. Am J Dis Child, 137:962, 1983.PubMedGoogle Scholar
  77. 77.
    Pressman MR, Figueroa WG, Kendrick-Mohamed J, Greenspon LW, Peterson DD: Nocturia. A rarely recognised symptom of sleep apnea and other occult sleep disorders. Arch Intern Med, 156(5):545, 1996.PubMedCrossRefGoogle Scholar
  78. 78.
    Ramsden PD: DDAVP for adult enuresis — a preliminary report. ICS 11th Annual Meeting, 1979.Google Scholar
  79. 79.
    Rembratt A, Mattiasson A: The prevalence of nocturia in the general population. ICS abstracts, p. 201–202, Sept, 1998.Google Scholar
  80. 80.
    Reynard JM, Cannon A, Yang Q, Abrams P: A novel therapy for nocturnal polyuria: a double-blind randomized trial of furosemide against placebo. Br J Urol, 81(2):215, 1998.PubMedCrossRefGoogle Scholar
  81. 81.
    Rittig S, Knudsen UB, Sorensen S, Djurhuus JC, Norgaard JP: Long-term, double-blind, cross-over study of desmopressin intranasal spray in the management of nocturnal enuresis. In: Meadow SR, editor. Desmopressin in nocturnal enuresis. Horus Medical Publication; p. 43, 1988.Google Scholar
  82. 82.
    Robinson AG: DDAVP in the treatment of diabetes insipidus. N Engl J Med, 294:507, 1976.PubMedCrossRefGoogle Scholar
  83. 83.
    Rollema H.: Clinical significance of symptoms, signs, and urodynamic parameters in benign prostatic hypertrophy. In: Krane RJ, Siroky MB, Fitzpatrick JM, editors. Clinical Urology. Philadelphia: J.P. Lippincott Company, p 859–860, 1994.Google Scholar
  84. 84.
    Saito M, Kondo A, Kato T, Yamada Y: Frequency-volume charts: Comparison of frequency between elderly and adult patients. Brit J Urol, 72(1):38, 1993.PubMedCrossRefGoogle Scholar
  85. 85.
    Shah PJR: The assessment of patients with a view to urodynamics. In: Mundy AR, Stephenson TP, Wein AJ, editors. Urodynamics — Principles, Practice and Application. Edinburgh: Churchill Livingstone; p. 85–93, 1994.Google Scholar
  86. 86.
    Sommer P, Nielsen KK, Bauer T, Kristensen ES, Hermann GG, Steven K, et al: Voiding patterns in men evaluated by a questionnaire survey. Brit J Urol, 65:155, 1990.PubMedCrossRefGoogle Scholar
  87. 87.
    Stachenfeld NS, Mack GW, Takamata A, DiPietro L, Nadel ER: Thirst and fluid regulatory responses to hypertonicity in older adults. Am J Physiol, 271(3 Pt 2):R757, 1996.PubMedGoogle Scholar
  88. 88.
    Stenberg A, Lackgren G: Desmopressin tablets in the treatment of severe nocturnal enuresis in adolescents. Pediatrics, 94:841, 1992.Google Scholar
  89. 89.
    Stewart RB, Moore MT, May FE, Marks RG, Hale WE: Nocturia a risk factor for falls in the elderly. J Am Geriatrics Soc, 40(12): 1217, 1992.Google Scholar
  90. 90.
    Suchowersky O, Furtado S, Rohs G.: Beneficial effect of desmopressin for nocturnal polyuria in parkinson’s disease. Mov Disord, 10(3):337, 1995.PubMedCrossRefGoogle Scholar
  91. 91.
    Sullivan MP, Yalla SV: Urodynamic assessment of benign prostatic hypertrophy. In: Romas NA, Vaughan ED, editors. Alternate Methods in the Treatment of Benign Prostatic Hyperplasia. Berlin: Springer-Verlag; p 66–89, 1993.CrossRefGoogle Scholar
  92. 92.
    Swithinbank LV, Donovan J, James MC, Yang Q, Abrams P: Female urinary symptoms: age prevalence in a community dwelling population using a validated questionnaire [Abstract]. Neurourol Urodyn, 16(5):432, 1998.Google Scholar
  93. 93.
    Swithinbank LV, Donovan J, Shepherd AM, Abrams P: Female urinary symptoms: just how much bother are they? [Abstract] Neurourol Urodyn, 16(5):431, 1998.Google Scholar
  94. 94.
    Takami N, Okada A: Triazolam and nitrazepam use in elderly outpatients. Ann Pharmacother, 27(4):506, 1993.PubMedGoogle Scholar
  95. 95.
    Terho P, Kekomaki M: Management of nocturnal enuresis with a vasopresin analogue. J Urol, 131:925, 1984.PubMedGoogle Scholar
  96. 96.
    Terho P: Desmopressin in nocturnal enuresis. J Urol, 145:818, 1991.PubMedGoogle Scholar
  97. 97.
    Tuvemo T: DDAVP in child and nocturnal enuresis. Acta Paediatr Scand, 67:7535, 1978.CrossRefGoogle Scholar
  98. 98.
    Umlauf MG, Goode S, Burgio KL: Psychosocial issues in geriatric urology: problems treatment and treatment seeking. Urol Clin North Am, 23(1):127, 1996.PubMedCrossRefGoogle Scholar
  99. 99.
    Valiquette G, Herbert J, Meade-D’Alisera P: Desmopressin in the management of nocturia in patients with multiple sclerosis. Arch Neurol, 53:1270, 1996.PubMedCrossRefGoogle Scholar
  100. 100.
    van Cauter E, Copinschi G: Altered hormonal secretions in aging: roles of sleep and circadian rhythms [Abstract]. The Aging Male, 1(Suppl 1):8, 1998.Google Scholar
  101. 101.
    van Kerrebroeck PEV, Scherpenhuizen S, Scholten H, et al.: Adult nocturnal enuresis: long-term effect of intranasally administered desmopressin. Abstract 20th Annual Meeting ICS. Aarhus, Denmark. September, 1990.Google Scholar
  102. 102.
    Westgren U, Wittstrom C, Harris AS: Oral desmopressin in central diabetes insipidus. Arch Dis Child, 61:247, 1986.PubMedCrossRefGoogle Scholar
  103. 103.
    Widerlov E, Sjostrom R, Soderberg U.: DDAVP and lithium-induced polyuria/polydipsia. Lancet, 2:1080, 1977.PubMedCrossRefGoogle Scholar
  104. 104.
    Weiss JP, Stember DS, Blaivas JG: Nocturia in Adults: Classification and etiology. Neurourol Urodyn, 16:401, 1997.Google Scholar
  105. 105.
    Weiss JP, Stember DS, Chaikin DC, Blaivas JG: Evaluation of the Etiology of Nocturia in Men: The Nocturia and Nocturnal Bladder Capacity Indices. Neurourol Urodyn, 18:559, 1999.PubMedCrossRefGoogle Scholar
  106. 106.
    Yalkut D, Lee LY, Grider J, Jorgensen M, Jackson B, Ott C: Mechanism of atrial natriuretic peptide release with increased inspiratory resistance. J Lab Clin Med, 128:322, 1996.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2003

Authors and Affiliations

  • Jeffrey P. Weiss
    • 1
  • Jerry G. Blaivas
    • 1
  1. 1.Cornell Medical CenterNew York HospitalNew YorkUSA

Personalised recommendations